Dr. Emily Ko on the Role of Surgery in Endometrial Cancer

Emily Ko, MD
Published: Sunday, Mar 20, 2016



Emily Ko, MD, assistant professor of Obstetrics and Gynecology, University of Pennsylvania Health System, discusses the role of surgery in endometrial cancer and the candidacy of patients for the procedure. Unlike other cancer types, Ko says surgery is an upfront treatment for the patients with endometrial cancer. She adds that while surgery is common and normally the best treatment, patient risk factors such as current health and comorbidities must be taken into account prior to a decision being made.

Ko says surgery is the best option due to endometrial cancers normally being confined to the uterus, and being able to rid the patients of their disease upfront generally portends a positive diagnosis. She adds that some forms of endometrial cancer will present early on with metastases, at which point chemotherapy treatment may be a better option.

<<< View more from the 2016 SGO Annual Meeting



Emily Ko, MD, assistant professor of Obstetrics and Gynecology, University of Pennsylvania Health System, discusses the role of surgery in endometrial cancer and the candidacy of patients for the procedure. Unlike other cancer types, Ko says surgery is an upfront treatment for the patients with endometrial cancer. She adds that while surgery is common and normally the best treatment, patient risk factors such as current health and comorbidities must be taken into account prior to a decision being made.

Ko says surgery is the best option due to endometrial cancers normally being confined to the uterus, and being able to rid the patients of their disease upfront generally portends a positive diagnosis. She adds that some forms of endometrial cancer will present early on with metastases, at which point chemotherapy treatment may be a better option.

<<< View more from the 2016 SGO Annual Meeting


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™May 25, 20182.0
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Publication Bottom Border
Border Publication
x